Alpha-lipoic acid and cardiovascular disease

Area of Science:

• Biochemistry
• Cardiovascular Science
• Nutritional Science

Background:

• Alpha-lipoic acid (ALA) is a naturally occurring antioxidant with potent ROS scavenging abilities.
• ALA and its reduced form, dihydrolipoic acid (DHLA), are effective in combating oxidative stress due to their solubility in both aqueous and lipid environments.
• ALA plays a role in recycling other vital antioxidants like vitamins C and E, and glutathione.

Purpose of the Study:

• To review existing literature on alpha-lipoic acid (ALA) concerning cardiovascular disease (CVD).
• To describe the most effective actions and potential applications of ALA as a natural antioxidant for CVD risk reduction.

Main Methods:

• Literature review of studies investigating ALA's effects on oxidative stress, antioxidant activity, and cardiovascular risk factors.
• Analysis of research on ALA's lipid-modulating properties, LDL oxidation protection, and hypertension modulation.

Main Results:

• ALA demonstrates significant antioxidant capacity by quenching reactive oxygen species (ROS).
• Evidence suggests ALA's role in modulating blood lipids, protecting LDL from oxidation, and influencing hypertension.
• ALA shows potential as a protective agent against cardiovascular disease (CVD) risk factors.

Conclusions:

• Alpha-lipoic acid (ALA) exhibits promising cardioprotective properties through its antioxidant and lipid-modulating effects.
• Despite extensive research, optimal ALA supplementation protocols (dosage, frequency, form) require further investigation.
• ALA represents a potential therapeutic agent for cardiovascular health, warranting continued research into its clinical applications.